OMNIPODPROMISE Trademark

Trademark Overview

On Monday, June 14, 2021, a trademark application was filed for OMNIPODPROMISE with the United States Patent and Trademark Office. The USPTO has given the OMNIPODPROMISE trademark a serial number of 90772649. The federal status of this trademark filing is REGISTERED as of Tuesday, March 7, 2023. This trademark is owned by Insulet Corporation. The OMNIPODPROMISE trademark is filed in the Advertising, Business and Retail Services category with the following description:

Providing a trade-in and upgrade program for drug delivery and diabetes management devices
omnipodpromise

General Information

Serial Number90772649
Word MarkOMNIPODPROMISE
Filing DateMonday, June 14, 2021
Status700 - REGISTERED
Status DateTuesday, March 7, 2023
Registration Number6997638
Registration DateTuesday, March 7, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 19, 2022

Trademark Statements

Pseudo MarkOMNI POD PROMISE
Goods and ServicesProviding a trade-in and upgrade program for drug delivery and diabetes management devices

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, September 1, 2021
Primary Code035
First Use Anywhere DateThursday, August 5, 2021
First Use In Commerce DateThursday, August 5, 2021

Trademark Owner History

Party NameInsulet Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressActon, MA 01720
Party NameInsulet Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressActon, MA 01720
Party NameInsulet Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressActon, MA 01720

Trademark Events

Event DateEvent Description
Wednesday, September 13, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, March 7, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 7, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, January 31, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, January 30, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 17, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 13, 2022USE AMENDMENT FILED
Friday, January 13, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 13, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, June 14, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 19, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 14, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 14, 2022EXAMINER'S AMENDMENT ENTERED
Monday, March 14, 2022ASSIGNED TO LIE
Saturday, March 12, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, March 12, 2022EXAMINERS AMENDMENT E-MAILED
Saturday, March 12, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, March 3, 2022ASSIGNED TO EXAMINER
Wednesday, September 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 17, 2021NEW APPLICATION ENTERED

Related Keywords

omnipodpromise diabetes management devices delivery drug trade upgrade program providing